查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403348

心血管设备的全球市场预测（~2030 年）：按设备类型、应用、最终用户和地区进行分析

Cardiovascular Devices Market Forecasts to 2030 - Global Analysis By Device Type, Application (Coronary Artery Disease, Heart Failure, Cardiac Arrhythmia and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球心血管器材市场规模为656.6亿美元，预计2030年将达1,271.5亿美元，预测期内复合年增长率为9.9%。

循环系统设备是用于诊断、治疗和监测疾病和循环系统的医疗设备。它透过治疗多种心血管疾病，包括心律不整、冠状动脉疾病和心臟衰竭，在医学上发挥重要作用。例如心律调节器、心臟去颤器、诊断成像设备、监测系统和导管。这些设备的重要性源自于它们提供有效治疗方法、促进准确诊断和改善患者治疗效果的能力。

根据世界卫生组织 (WHO) 的数据，大约 75% 与心血管疾病相关的死亡发生在低收入和中等收入国家。

心血管疾病盛行率上升

心臟衰竭、心律不整和冠状动脉疾病 (CADD) 等心血管疾病 (CVD) 盛行率的上升是由多种因素造成的，包括久坐的生活方式、不健康的饮食、吸烟和高龄化。日益增加的疾病负担增加了对创新心血管设备和技术的需求。置入式除颤器（ICD）、起搏器、药物释放型支架和心臟监测设备等设备在各种心血管疾病的诊断、治疗和管理中发挥着至关重要的作用。这些先进技术有助于改善患者预后、降低死亡率并提高患者的整体生活品质。因此，对市场拓展的需求日益增加。

研究和开发活动的障碍增加

加强监管、更严格的安全标准以及大规模临床试验的需求显着增加了研发成本和时间。这些障碍对小型企业和新兴企业影响尤其严重，限制了他们进入市场和创新的能力。现有公司也面临需要大量投资研发的障碍。这些高昂的研发障碍阻碍了新心血管设备的及时推出，阻碍了创新和市场成长。

远端医疗和远端监控

远端医疗和远端监控透过即时远端监控生命体征、心率和其他相关资料，促进持续的患者护理。对于心血管患者来说，它提供了家庭监测的便利性、减少了医院就诊次数并改善了获得护理的机会。先进的可穿戴设备、行动应用程式和连网型平台使医疗保健专业人员能够远端评估患者状况、及时采取干预措施并提供个人化护理，最终帮助患者改善治疗结果。远端医疗和远端监测在循环系统中的整合也将为创新铺平道路，并促进开发更先进、用户友好且有效的循环系统设备，专为远端监测和远端医疗应用而设计。

严格规定

不断变化和严格的监管要求可能会导致核准流程更长、合规成本更高以及引入新设备的障碍增加。这些法规可能会抑制创新和市场进入，特别是对于资源有限、难以应对复杂监管环境的中小型企业。此外，监管变化和不确定性可能会扰乱现有的市场策略和投资，影响产品开发时间表和市场竞争力。

COVID-19 的影响

COVID-19 的疫情以各种方式对心血管设备市场产生了重大影响。最初，重点转向控制大流行，由于医疗保健资源的重新分配和患者不愿意接受非紧急治疗，导致心血管疾病的择期手术和诊断减少。供应链中断和製造限制也影响了设备的可用性。然而，疫情加速了远端医疗和远端监控解决方案的采用，并刺激了心血管护理数位健康领域的创新。随着疫苗接种率的提高和卫生系统适应新常态，选择性手术逐渐恢復。

诊断和监测设备领域预计将在预测期内成为最大的领域

由于旨在检测、监测和评估心血管疾病的先进技术，诊断和监测设备领域预计将占据最大份额。这些设备可以即时监测心律、血压和其他生命体征，有助于及早发现异常情况并促进持续的患者照护。此外，这些设备在各种心血管疾病的诊断中发挥着至关重要的作用，为医疗保健专业人员提供了准确评估、个人化治疗策略和改善患者治疗结果的关键资料，最终有助于更好地管理和护理心臟病。

预计冠状动脉疾病（CAD）领域在预测期内复合年增长率最高。

冠状动脉疾病（CAD）领域预计在预测期内将出现良好的成长。冠状动脉疾病 (CAD) 是指向心臟供应富氧血液的冠状动脉变窄或阻塞。这些装置有助于恢復心臟的血液流动、缓解症状并降低心臟病发作的风险。 CAD专用设备支援经皮冠状动脉介入（PCI）和冠状动脉绕道手术手术（CABG）介入，改善这种常见心血管疾病的管理，改善患者的心臟健康和生活质量，并发挥至关重要的改善作用。

比最大的地区

在估计期间，亚太地区占据最大的市场占有率。亚太地区拥有多元化的医疗技术，主要集中在中国、印度和日本等国家治疗心臟相关疾病。这个快速成长的市场的特点是心律管理设备、支架、诊断工具等方面的进步。此外，心血管疾病发生率的增加、医疗基础设施的改善以及创新医疗解决方案的持续采用等因素也促进了市场的扩张。由于技术创新的整合和医疗意识的不断提高，亚太地区对心血管设备的需求正在激增。

复合年增长率最高的地区：

以美国和加拿大为主要贡献者的北美地区由于其强劲和成熟的形势，预计在预测期内将实现盈利增长。该市场以其先进的医疗技术而闻名，包括各种心血管设备，包括起搏器、心臟去颤器、支架和成像工具。此外，高额医疗支出、先进的医疗基础设施和庞大的患者群等因素正在推动市场成长。微创手术的创新加上对研究和开发的重视，有助于该地区在尖端心血管技术方面处于领先地位，并创造一个专注于改善患者治疗结果的竞争市场环境。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球心血管设备市场：按设备类型

  • 诊断/监测装置
    • 远端心臟监测
    • 心电图（ECG）
  • 治疗/手术设备
    • 心臟辅助装置
    • 导管
    • 心率管理装置
    • 接枝
    • 支架
    • 心臟瓣膜
  • 其他设备类型

第六章全球心血管设备市场：依应用分类

  • 冠状动脉疾病（CAD）
  • 心臟衰竭
  • 心律不整
  • 其他用途

第七章全球心血管设备市场：依最终用户分类

  • 专科诊所
  • 医院
  • 心臟中心
  • 门诊外科中心

第八章全球心血管设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Abbott
  • Cardinal Health
  • Boston Scientific Corporation
  • General Electric（GE Healthcare）
  • Medtronic
  • WL Gore & Associates, Inc.
  • Biotronik
  • Canon Medical Systems Corporation
  • Siemens Healthcare Gmbh
  • Edwards Lifesciences Corporation
  • Livanova PLC
  • B. Braun Melsungen AG
  • Johnson & Johnson Services, Inc.
  • Terumo Cardiovascular Systems Corporation
  • Philips Healthcare
  • Microport Scientific Corporation
  • Lepu Medical Technology（Beijing）Co Ltd
  • Occlutech
  • Getinge AB
  • Atricure, Inc
简介目录
Product Code: SMRC24573

According to Stratistics MRC, the Global Cardiovascular Devices Market is accounted for $65.66 billion in 2023 and is expected to reach $127.15 billion by 2030 growing at a CAGR of 9.9% during the forecast period. Cardiology devices are medical equipment intended to diagnose, treat, and monitor diseases and cardiovascular systems. They play a vital role in healthcare by treating a range of cardiovascular disorders, including arrhythmias, coronary artery disease, and heart failure. Some of these devices are pacemakers, defibrillators, imaging equipment, monitoring systems, and catheters. Their importance derives from their capacity to provide effective treatment initiatives, facilitate precise diagnosis, and improve patient outcomes-all of which significantly raise standards for cardiac health and save lives.

According to the World Health Organization, around 75% of the cardiovascular diseases related deaths occur in low and middle income countries.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases (CVDs) such heart failure, arrhythmias, and coronary artery disease (CADD) is attributed to several factors, including sedentary lifestyles, unhealthy diets, tobacco use, and ageing populations. This escalating disease burden necessitates a greater demand for innovative cardiovascular devices and technologies. Devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, drug-eluting stents, and cardiac monitoring devices play pivotal roles in diagnosing, treating, and managing various cardiovascular conditions. These advanced technologies aid in improving patient outcomes, reducing mortality rates, and enhancing the overall quality of life for affected individuals. Therefore, there is an increasing demand for market expansion.

Restraint:

Increasing barriers in R&D activities

Heightened regulatory scrutiny, demanding safety standards, and the necessity for extensive clinical trials significantly elevate R&D costs and timelines. These barriers disproportionately affect smaller companies and start-ups, limiting their ability to enter the market and innovate. Established players also encounter impediments, requiring substantial investments in R&D. These mounting hurdles in R&D hinder the timely introduction of novel cardiovascular devices, impeding innovation and market growth.

Opportunity:

Telemedicine and remote monitoring

Telemedicine and remote monitoring facilitate continuous patient care by enabling remote monitoring of vital signs, cardiac rhythms, and other relevant data in real-time. For cardiovascular patients, this offers the convenience of home-based monitoring, reducing hospital visits, and enhancing accessibility to healthcare. Advanced wearable devices, mobile apps, and connected platforms allow healthcare professionals to remotely assess patients' conditions, provide timely interventions, and offer personalised care, ultimately improving patient outcomes. The integration of telemedicine and remote monitoring in cardiovascular also opens avenues for innovation, driving the development of more sophisticated, user-friendly, and effective cardiovascular devices tailored for remote monitoring and telehealth applications.

Threat:

Stringent regulations

Evolving and stringent regulatory requirements can result in prolonged approval processes, increased compliance costs, and heightened barriers for new device introductions. These regulations may inhibit innovation and market entry, particularly for smaller companies with limited resources to navigate complex regulatory landscapes. Also, regulatory changes or uncertainties might disrupt existing market strategies and investments, impacting product development timelines and market competitiveness.

COVID-19 Impact

The COVID-19 pandemic significantly affected the cardiovascular device market in various ways. Initially, the focus shifted towards managing the pandemic, causing a decline in elective procedures and diagnostics for cardiovascular conditions due to healthcare resource reallocation and patient reluctance to seek non-emergency care. Supply chain disruptions and manufacturing constraints also impacted device availability. However, the pandemic accelerated the adoption of telemedicine and remote monitoring solutions, driving innovation in digital health for cardiovascular care. As vaccination rates increased and healthcare systems adapted to the new normal, there was a gradual rebound in elective procedures.

The Diagnostic and Monitoring Devices segment is expected to be the largest during the forecast period

The Diagnostic and Monitoring Devices segment is estimated to hold the largest share, due to the advanced technologies designed to detect, monitor, and assess cardiovascular conditions. They enable real-time monitoring of heart rhythms, blood pressure, and other vital signs, aiding in the early detection of abnormalities and facilitating continuous patient care. Additionally, these devices play a pivotal role in diagnosing various cardiovascular diseases, providing healthcare professionals with crucial data for accurate assessments, personalised treatment strategies, and improved patient outcomes, ultimately contributing to better management and care of cardiac

The Coronary Artery Disease (CAD) segment is expected to have the highest CAGR during the forecast period

The Coronary Artery Disease (CAD) segment is anticipated to have lucrative growth during the forecast period. Coronary artery disease (CAD) is a narrowing or blockage of your coronary arteries, which supply oxygen-rich blood to the heart. These devices help restore blood flow to the heart, alleviate symptoms, and reduce the risk of heart attacks. CAD-specific devices aid in interventions such as percutaneous coronary interventions (PCI) and coronary artery bypass grafting (CABG), playing a pivotal role in managing this prevalent cardiovascular condition and improving patients' cardiac health and quality of life.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. It encompasses a diverse landscape of medical technologies focused on treating heart-related conditions across countries like China, India, Japan, and others. This rapidly growing market features advancements in cardiac rhythm management devices, stents, diagnostic tools, and more. Moreover, factors such as rising cardiovascular diseases, improving healthcare infrastructure, and increasing adoption of innovative medical solutions contribute to the market's expansion. With a blend of technological innovation and growing healthcare awareness, the Asia Pacific region is witnessing a surge in demand for cardiovascular devices.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to its robust and mature landscape, encompassing the United States and Canada as key contributors. Known for its advanced medical technologies, this market hosts a wide array of cardiovascular devices, including pacemakers, defibrillators, stents, and imaging tools. Furthermore, factors such as high healthcare spending, sophisticated healthcare infrastructure, and a large patient pool drive market growth. Innovations in minimally invasive procedures, coupled with a strong emphasis on research and development, contribute to the region's leadership in cutting-edge cardiovascular technologies, fostering a competitive market environment with a focus on improving patient outcomes

Key players in the market:

Some of the key players in the Cardiovascular Devices Market include Abbott, Cardinal Health, Boston Scientific Corporation, General Electric (GE Healthcare), Medtronic, W. L. Gore & Associates, Inc., Biotronik, Canon Medical Systems Corporation, Siemens Healthcare GmbH., Edwards Lifesciences Corporation, LivaNova PLC, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., Terumo Cardiovascular Systems Corporation, Philips Healthcare, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co Ltd, Occlutech, Getinge AB and AtriCure, Inc.

Key Developments:

In October 2022, Medtronic plc received United States FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods, such as cardiomyopathy.

In October 2022, Biosense Webster, Inc., part of Johnson & Johnson MedTech launched the HELIOSTAR Balloon Ablation Catheter in Europe. The HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.

Device Types Covered:

  • Diagnostic and Monitoring Devices
  • Therapeutic and Surgical Devices
  • Other Device Types

Applications Covered:

  • Coronary Artery Disease (CAD)
  • Heart Failure
  • Cardiac Arrhythmia
  • Other Applications

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Cardiac Centers
  • Centers Ambulatory Surgical

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cardiovascular Devices Market, By Device Type

  • 5.1 Introduction
  • 5.2 Diagnostic and Monitoring Devices
    • 5.2.1 Remote Cardiac Monitoring
    • 5.2.2 Electrocardiogram (ECG)
  • 5.3 Therapeutic and Surgical Devices
    • 5.3.1 Cardiac Assist Devices
    • 5.3.2 Catheters
    • 5.3.3 Cardiac Rhythm Management Devices
    • 5.3.4 Grafts
    • 5.3.5 Stents
    • 5.3.6 Heart Valves
  • 5.4 Other Device Types

6 Global Cardiovascular Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Coronary Artery Disease (CAD)
  • 6.3 Heart Failure
  • 6.4 Cardiac Arrhythmia
  • 6.5 Other Applications

7 Global Cardiovascular Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Cardiac Centers
  • 7.5 Centers Ambulatory Surgical

8 Global Cardiovascular Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest Of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest Of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest Of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest Of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations And Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott
  • 10.2 Cardinal Health
  • 10.3 Boston Scientific Corporation
  • 10.4 General Electric (GE Healthcare)
  • 10.5 Medtronic
  • 10.6 W. L. Gore & Associates, Inc.
  • 10.7 Biotronik
  • 10.8 Canon Medical Systems Corporation
  • 10.9 Siemens Healthcare Gmbh
  • 10.10 Edwards Lifesciences Corporation
  • 10.11 Livanova PLC
  • 10.12 B. Braun Melsungen AG
  • 10.13 Johnson & Johnson Services, Inc.
  • 10.14 Terumo Cardiovascular Systems Corporation
  • 10.15 Philips Healthcare
  • 10.16 Microport Scientific Corporation
  • 10.17 Lepu Medical Technology(Beijing)Co Ltd
  • 10.18 Occlutech
  • 10.19 Getinge AB
  • 10.20 Atricure, Inc

List Of Tables

  • Table 1 Global Cardiovascular Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 3 Global Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 4 Global Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 5 Global Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 6 Global Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 7 Global Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 8 Global Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 9 Global Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 10 Global Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 11 Global Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 12 Global Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 13 Global Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 Global Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 15 Global Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 16 Global Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 17 Global Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 20 Global Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 22 Global Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 23 North America Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 25 North America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 26 North America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 27 North America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 28 North America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 29 North America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 30 North America Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 31 North America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 32 North America Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 33 North America Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 34 North America Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 35 North America Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 37 North America Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 38 North America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 39 North America Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 40 North America Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 North America Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 42 North America Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 44 North America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 45 Europe Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 47 Europe Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 48 Europe Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 49 Europe Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 50 Europe Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 51 Europe Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 52 Europe Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 53 Europe Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 54 Europe Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 55 Europe Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 56 Europe Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 57 Europe Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Europe Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 59 Europe Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 60 Europe Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 61 Europe Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 62 Europe Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 63 Europe Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 64 Europe Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 66 Europe Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 67 Asia Pacific Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 70 Asia Pacific Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 71 Asia Pacific Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 72 Asia Pacific Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 73 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 74 Asia Pacific Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 75 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 76 Asia Pacific Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 77 Asia Pacific Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 78 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 79 Asia Pacific Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 80 Asia Pacific Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 81 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 82 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 83 Asia Pacific Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 84 Asia Pacific Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 85 Asia Pacific Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 86 Asia Pacific Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 88 Asia Pacific Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 89 South America Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 91 South America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 92 South America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 93 South America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 94 South America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 95 South America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 96 South America Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 97 South America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 98 South America Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 99 South America Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 100 South America Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 101 South America Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 102 South America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 103 South America Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 104 South America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 105 South America Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 106 South America Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 107 South America Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 108 South America Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 110 South America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 111 Middle East & Africa Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 114 Middle East & Africa Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 115 Middle East & Africa Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 116 Middle East & Africa Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 117 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 118 Middle East & Africa Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 119 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 120 Middle East & Africa Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 121 Middle East & Africa Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 122 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 123 Middle East & Africa Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 124 Middle East & Africa Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 126 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 127 Middle East & Africa Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 128 Middle East & Africa Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 129 Middle East & Africa Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 130 Middle East & Africa Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 132 Middle East & Africa Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)